Search results
Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide...
FOX 5 San Diego· 14 hours agoImmunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune ...
Corcept Therapeutics Inc (CORT) Outperforms Analyst Estimates in Q1 2024
GuruFocus.com via Yahoo Finance· 3 hours agoOverall, Corcept Therapeutics Inc's first-quarter performance not only underscores its financial...
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies...
FOX 4 Kansas City· 6 days agoGordian Biotechnology, an in vivo drug discovery and development company, today announced its...
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
InvestorPlace· 7 hours agoIn other words, these are ideas that, by the numbers, should benefit from Wall Street’s spotlight. A...
A Yeast-Like Bacteria Can Cut Carbon Emissions While Creating Sustainable Aviation Fuel and Sneakers
The Wall Street Journal· 15 hours agoSteel producers are looking to reduce their operating emissions. And sports-apparel makers are...
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies...
The Record Gazette· 6 days agoGordian Biotechnology Scientists Process Tissue From a Mosaic Screening in the Company’s South San Francisco Headquarters
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 11 hours agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
Maia Biotechnology director buys $39,919 in company shares By Investing.com
Investing.com· 5 days agoMAIA Biotechnology, Inc. (NYSE:MAIA) director Louie Ngar Yee acquired a significant number of...
Amgen investors await weight-loss drug data
Reuters via Yahoo Finance· 14 hours ago(Reuters) -Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company...
Maia Biotechnology director Smith acquires shares worth $299,408 By Investing.com
Investing.com· 5 days agoMAIA Biotechnology, Inc. (NYSE:MAIA), a company specializing in pharmaceutical preparations, has...